Liver transplantation for cholangiocarcinoma

Transplantation

Volumn 88, Issue 3, 2009, Pages 295-298

  Schwartz, Jason J ^a   Hutson, William R ^b   Gayowski, Timothy J ^a   Sorensen, John B ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Cholangiocarcinoma; Liver transplantation; Neoadjuvant therapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; BILE DUCT CARCINOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; HEALTH CARE POLICY; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; LIVER TRANSPLANTATION; METASTASIS; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; HEALTH SERVICES ACCESSIBILITY; HUMANS; LIVER TRANSPLANTATION; NEOADJUVANT THERAPY; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, ADJUVANT; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 69449103568     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181adc9e5     Document Type: Review

References (37)

1. Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993; 166: 768. (Pubitemid 24309361)
2. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: Results in 207 patients. Transplantation 2000; 69: 1633. (Pubitemid 30845611)
3. Brandsaeter B, Isoniemi H, Broome U, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004; 40: 815. (Pubitemid 38507363)
4. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242: 451.
5. Hassoun Z, Gores GJ, Rosen CB. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin N Am 2002; 11: 909. (Pubitemid 35397229)
6. De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6: 309. (Pubitemid 30317226)
7. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693. (Pubitemid 26079803)
8. Callery MP. Transplantation for cholangiocarcinoma: Advance or supply- demand dilemma? Gastroenterology 2006; 130: 2242.
9. Becker NS, Rodriguez JA, Barshes NR, et al. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 2008; 12: 117.
10. Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002; 2: 774. (Pubitemid 36342621)
11. Robles R, Figueras J, Turrion VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004; 239: 265. (Pubitemid 38176362)
12. Gores GJ, Gish RG, Sudan D, et al. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 2006; 12 (S3): S95. (Pubitemid 44911780)
13. Review Board Coordination Supervisor. UNOS Department of Evaluation and Quality, 2009.
14. Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006; 82: 1703.
15. United Network for Organ Sharing. Available at: http://www.optn.org/ data, 2008: http://www.optn.org/data.
16. United Network for Organ Sharing. Available at: http://unos.org, 2008: http://unos.org.
17. Bismuth H, Castaing D, Ericzon BG, et al. Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet 1987; 2: 674. (Pubitemid 17122884)
18. O'Grady JG, Polson RJ, Rolles K, et al. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988; 207: 373.
19. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224: 628. (Pubitemid 26384886)
20. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998; 187: 358. (Pubitemid 28467610)
21. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230: 808.
22. Pandey D, Lee KH, Tan KC. The role of liver transplantation for hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007; 6: 248. (Pubitemid 46925244)
23. Chollet P, Amat S, Cure H, et al. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer 2002; 86: 1041. (Pubitemid 34441058)
24. Stipa F, Chessin DB, Shia J, et al. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006; 13: 1047. (Pubitemid 44337963)
25. Sanghera P, Wong DW, McConkey CC, et al. Chemoradiotherapy for rectal cancer: An updated analysis of factors affecting pathological response. Clin Oncol (R Coll Radiol) 2008; 20: 176.
26. Chen SC, Chang HK, Lin YC, et al. High pathologic complete response inHER2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin. Jpn J Clin Oncol 2008; 38: 99.
27. Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: Patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998; 228: 385.
28. Grove MK, Hermann RE, Vogt DP, et al. Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg 1991; 161: 454.
29. Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: Analysis of 46 patients. Arch Surg 2004; 139: 514. (Pubitemid 38585751)
30. Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: Results of a prospective study. Ann Surg 2004; 240: 95. (Pubitemid 38808240)
31. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230: 663. (Pubitemid 30191828)
32. Jang JY, Kim SW, Park DJ, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 2005; 241: 77.
33. Todoroki T, Kawamoto T, Koike N, et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 2000; 87: 306. (Pubitemid 30156356)
34. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507. (Pubitemid 32946713)
35. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995; 130: 270.
36. Farley DR, Weaver AL, Nagorney DM. "Natural history" of unresected cholangiocarcinoma: Patient outcome after noncurative intervention. Mayo Clin Proc 1995; 70: 425.
37. Konstadoulakis MM, Roayaie S, Gomatos IP, et al. Aggressive surgical resection for hilar cholangiocarcinoma: Is it justified? Audit of a single center's experience. Am J Surg 2008; 196: 160. (Pubitemid 351970509)